PHARMACOLOGY

Course Description

Pharmacology II is the continuation of the Pharmacology I course. The main topics of Pharmacology II is consist of cardiovascular system drugs (antihypertensive drugs, diuretics and drugs affecting acid-base balance, drugs that are used in angina and other myocardial ischemia and the treatment of myocardial ischemia, drugs used for congestive heart disease, antiarrhytmic drugs, antithrombotic drugs, drugs that are used for hyperlipidemia, peripherial vasodilators and antianemic drugs). After completing cardiovascular system pharmacology central nervous system pharmacology will be introduced. In central nervous system pharmacology; general and local anesthetics, sedative-hypnotics, neuroleptics, anxyolitics, antidepressants, pain management and classification and analgesics, non-steroidal anti-inflammatory drugs, anti-epileptics and anti-Parkinson drugs will be covered.

PHARMACOLOGY

Evaluation Tools (Active Term)

No evaluation items have been defined.

Course outcomes

1. 01 1.Be able to explain Basic principles of pharmacology including receptor mechanisms
2. 02 2.Be able to describe Drug distribution and metabolism,Drug Receptors
3. 03 3.Be able to explain Antiepileptics drugs,Antidepressants drug
4. 04 4.Be able to explain GABA and Glycine) and neurotransmission in the brain.
5. 05 5.Be able to evaluate narcotic and non-narcotic analgesics,
6. 06 6.Be able to explain evaluate narcotic and non-narcotic analgesics
7. 07 7.Be able to explain their uses accoring to the condition and their pharmacokinetic and pharmacodynamic properties.
8. 08 8.Be able to describe drugs used for heart failure and drugs used for fluid and electrolyte disorders,
9. 09 9.Be able to explain their uses accoring to the condition and their pharmacokinetic and pharmacodynamic properties.

Course Syllabus

Reference Books & Course Materials

1. 01 Goodman and Gilman’s The Pharmacological Basis of Therapeutics, Eds: Brunton L.L., Hilal-Dandan R., Knollmann RC, McGrawHill, 13th Edition, 2016
2. 02 Basic and Clinical Pharmacology, Ed: Katzung BC. Lange, 14th Edition, 2017
3. 03 Basic and Clinical Pharmacology, Ed: Katzung BC, 14th edition, Lange, 2017
4. 04 Akılcıl Tedavi Yönünden Tıbbi Farmakoloji, Kayaalp O, 13. baskı, Pelikan Kitabevi, 2012

Learning Outcomes

No learning outcomes have been defined.

Program Outcomes

1. P01 1. Applies foundational nursing knowledge to meet individual, family, and community health needs by providing person-centred care that respects dignity, autonomy, privacy, and informed consent.
2. P02 2. Applies professional standards and quality management principles by using risk assessment, incident/near-miss reporting, audit/feedback, and continuous improvement to strengthen patient safety.
3. P03 3. Integrates theoretical and practical knowledge to deliver holistic preventive, curative, and rehabilitative nursing care by demonstrating therapeutic communication, empathy, and culturally safe practice.
4. P04 4. Delivers evidence-based, high-quality care using health information and communication technologies by documenting accurately, protecting confidentiality/data security, and using clinical technologies safely and appropriately.
5. P05 5. Identifies, analyses, and addresses healthcare problems by formulating clinical questions, searching and appraising evidence, applying findings to practice, and evaluating outcomes using a systematic, research-informed approach.
6. P06 6. Manages nursing care by prioritising, planning, implementing, and evaluating interventions; escalating concerns appropriately; and demonstrating accountability through accurate documentation and responsible delegation/supervision.
7. P07 7. Collaborates effectively within interdisciplinary/multidisciplinary teams by sharing timely information, respecting roles, engaging in constructive conflict management, and contributing actively to shared decision-making.
8. P08 8. Maintains lifelong learning by setting professional development goals, seeking and using feedback, engaging in reflective practice/portfolio work, and updating practice according to current scientific and technological developments.
9. P09 9. Plans and implements community-oriented projects and health promotion activities by using population data, collaborating with stakeholders, advocating for equitable health, and evaluating the impact of initiatives on community/public health.
10. P10 10. Upholds ethical principles by maintaining confidentiality, obtaining informed consent, ensuring fairness/non-discrimination, managing professional boundaries, and reporting unethical or unsafe practices according to regulations.
11. P11 11. Contributes to quality and professional development processes by participating in institutional quality activities , supporting in-field/out-of-field education through mentoring/teaching, and representing the nursing profession appropriately at national and international levels.
12. P12 12. Communicates professionally in at least one foreign language to access and use international evidence, collaborate with global peers, and provide safe, respectful communication for diverse populations.

Po-Lo Matrix

The PO-LO matrix has not been populated yet.